In vitro activity of the antifungal azoles itraconazole and posaconazole against Leishmania amazonensis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  De Macedo Silva, Sara Teixeira ^a,b   Urbina, Julio A ^c   De Souza, Wanderley ^a,b,d   Rodrigues, Juliany Cola Fernandes ^a,b,d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Centro Nacional de Ressonância Magnética Nuclear Jiri Jonas Instituto de Bioquímica Médica Leopoldo de Meis Instituto Nacional de Ciência e Tecnologia de Biologia Estrutural e Bioimagem   (Brazil)

^c INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^d INSTITUTO NACIONAL DE METROLOGIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENTS; ANTIPROTOZOAL AGENTS; DRUG REPOSITIONING; ENZYME INHIBITORS; INHIBITORY CONCENTRATION 50; ITRACONAZOLE; LEISHMANIA MEXICANA; LIFE CYCLE STAGES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; PROTOZOAN PROTEINS; STEROL 14-DEMETHYLASE; TRIAZOLES;

EID: 84893511390     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0083247     Document Type: Article

References (48)

1. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, et al. (2012) Leishmaniasis worldwide and global estimates of its incidence. PloS One 7: e35671.
2. Herwaldt BL. (1999) Leishmaniasis. Lancet 354: 1191-1199.
3. Grimaldi G Jr, McMahan-Pratt D. (1991) Leishmaniasis and its etiologic agents in the New World: an overview. Prog Clin Parasitol 2: 73-118.
4. Liew FY, O'Donnell CA. (1993) Immunology of leishmaniasis. Adv Parasitol 32: 161-259. (Pubitemid 23250335)
5. Barral A, Pedral-Sampaio D, Grimaldi Jr G, Momen H, McMahon-Pratt D, et al. (1991). Leishmaniasis in Bahia, Brazil: evidence that Leishmania amazonensis produces a wide spectrum of clinical disease. Am J Trop Med Hyg 44: 536-546.
6. Lainson R, Shaw JJ, Silveira FT, de Souza AAA, Braga RR, et al. (1994). The dermal leishmaniases of Brazil, with special reference to the eco-epidemiology of the disease in Amazonia. Mem Inst Oswaldo Cruz 89: 435-443.
7. Singh S, Sivakumar R. (2004) Challenges and new discoveries in the treatment of leishmaniasis. J infect Chemother 10: 307-315. (Pubitemid 40142819)
8. Goto H, Lindoso JAL. (2010) Current diagnosis and treatment of cutaneous and mucocutaneous leishmaniasis. Expert Rev Anti Infect Ther 8: 419-433.
9. Croft SL, Sundar S, Fairlamb AH. (2006) Drug resistance in leishmaniasis. Clin Microbiol Rev 19: 111-126. (Pubitemid 43157649)
10. Alvar JC, Cañavate C, Gutierrez-Solar B, Jimenez M, Laguna F, et al. (1997) Leishmania and human immunodeficiency vírus coinfection: the first 10 years. Clin Microbiol Rev 10: 298-319. (Pubitemid 27196673)
11. Rosenthal E, Marty P, Poizot-Martin I, Reynes J, Pratlong F, et al. (1995) Visceral leishmaniasis and HIV-1 co-infection in southern France. Trans R Soc Trop Med Hyg 89: 159-162.
12. Murray HW, Berman JD, Davies CR, Saravia NG (2005) Advances in leishmaniasis. Lancet 366: 1561-1577. (Pubitemid 41540115)
13. van Griensven J, Balasegaram M, Meheus F, Alvar J, Lynen L, et al. (2010) Combination therapy for visceral leishmaniasis. Lancet Infect Dis 10: 184-194.
14. Godinho JLP, Simas-Rodrigues C, Silva R, Ürmenyi TP, de Souza W, et al. (2012) Efficacy of miltefosine treatment in Leishmania amazonensis-infected Balb/C mice. Int J Antimicrob Ag 39: 326-331.
15. de Souza W, Rodrigues JCF. (2009) Sterol biosynthesis pathway as target for anti-trypanosomatid drugs. Interdiscip Perspect Infect Dis 2009: 642502.
16. Urbina JA, Docampo R. (2003) Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 19: 495-501. (Pubitemid 37329658)
17. Benaim G, Sanders JM, Garcia-Marchán Y, Colina C, Lira R, et al. (2006) Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. J Med Chem 49: 892-899. (Pubitemid 43221637)
18. Al-Abdely HM, Graybill JR, Loebenberg D, Melby PC. (1999) Efficacy of the triazole SCH 56592 against Leishmania amazonensis and Leishmania donovani in experimental murine cutaneous and visceral leishmaniases. Antimicrob Agents Chemother 43: 2910-2914.
19. Rodrigues JCF, Conception JL, Rodrigues C, Caldera A, Urbina JA, et al. (2008) In vitro activities of ER-119884 and E5700, two potent squalene synthase inhibitors, against Leishmania amazonensis: antiproliferative, biochemical, and ultrastructural effects. Antimicrob Agents Chemother 52: 4098-4114.
20. Rodrigues JCF, Bernardes CF, Visbal G, Urbina JA, Vercesi AE, et al. (2007) Sterol methenyl transferase inhibitors alter the ultrastructure and function of the Leishmania amazonensis mitochondrion leading to potent growth inhibition. Protist 158: 447-456. (Pubitemid 350153628)
21. 24(25)-sterol methyltransferase inhibitors, on promastigote and amastigote forms of Leishmania amazonensis. Antimicrob Agents Chemother 46: 487-499.
22. Perfect JR, Cox GM, Dodge RK, Schell WA. (1996) In vitro and in vivo efficacies of the azole SCH56592 against Cryptococcus neoformans. Antimicrob Agents Chemother 40: 1910-1913. (Pubitemid 26277814)
23. Faergemann J. (1984) In vitro and in vivo activities of ketoconazole and itraconazole against Pityrosporum orbiculare. Antimicrob Agents Chemother 26: 773-774.
24. Van Cutsem J, Van Gerven F, Van de Ven MA, Borgers M, Janssen PA. (1984) Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother 26: 527-534. (Pubitemid 14018091)
25. Espinel-Ingroff A, Shadomy S, Gebhart RJ. (1984) In vitro studies with R 51,211 (itraconazole). Antimicrob Agents Chemother 26: 5-9. (Pubitemid 14086712)
26. Uchida K, Yokota N, Yamaguchi H. (2001) In vitro antifungal activity of posaconazole against various pathogenic fungi. Int J Antimicrob Agents 18: 167-172. (Pubitemid 32757229)
27. Saag MS, Dismukes WE. (1988) Azole antifungal agents: emphasis on new triazoles. Antimicrob Agents Chemother 32: 1-8. (Pubitemid 18025667)
28. Alsip SA, Stamm AM, Dismukes WE. (1986) Ketoconazole, miconazole, and other imidazoles. In: Fungal Diseases of the Lung, Sarosi GA, Davies SF, editors. Orlando: Grune & Stratton. 335-376.
29. Urbina JA, Payares G, Contreras LM, Liendo A, Sanoja C, et al. (1998) Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies. Antimicrob Agents Chemother 42: 1771-1777. (Pubitemid 28311577)
30. Paniz-Mondolfi AE, Stavropoulos C, Gelanew T, Loucas E, Alvarez AMP, et al. (2011) Successful treatment of Old World cutaneous leishmaniasis caused by Leishmania amazonensis with posaconazole. Antimicrob Agents Chemother 55: 1774-1776.
31. Nassiri-Kashani M, Firooz A, Khamesipour A, Mojtahed F, Nilforoushzadeh M, et al. (2005) A randomized, double-blind, placebo-controlled clinical trial of itraconazole in the treatment of cutaneous leishmaniasis. Eur Acad Dermatol Venereol 19: 80-83. (Pubitemid 40268145)
32. Consigli J, Danielo C, Gallerano V, Papa M, Guidi A (2006). Cutaneous leishmaniasis: successful treatment with itraconazole. Int J Dermatol 45: 46-49.
33. Baroni A, Aiello FS, Vozza A, Vozza G, Faccenda F, et al. (2009) Cutaneous leishmaniasis treated with itraconazole. Dermatol Ther 22: S27-S29.
34. Warren LG. (1960) Metabolism of Schizotrypanum cruzi Chagas. I. Effect of culture age and substrate concentration on respiratory rate. J Parasitol 46: 529-539.
35. Henriques C, Moreira TLB, Maia-Brigagão C, Henriques-Pons A, Carvalho TMU, et al. (2011) Tetrazolium salt based methods for high-throughput evaluation of anti-parasite chemotherapy. Anal Methods 3: 2148-2155.
36. de Macedo-Silva ST, de Oliveira Silva TL, Urbina JA, de Souza W, Rodrigues JC. (2011) Antiproliferative, Ultrastructural, and Physiological Effects of Amiodarone on Promastigote and Amastigote Forms of Leishmania amazonensis. Mol Biol Int 2011: 876021.
37. Galgiani JN, Lewis ML. (1997) In vitro studies of activities of the antifungal triazoles SCH56592 and Itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts. Antimicrob Agents Chemother 41: 180-183. (Pubitemid 26428152)
38. Walther TC, Farese RV Jr. (2009) The life of lipid droplets. Biochim Biophys Acta 1791: 459-466.
39. Rodrigues JCF, de Souza W. (2008) Ultrastructural alterations in organelles of parasitic protozoa induced by different classes of metabolic inhibitors. Curr Pharm Des 14: 925-938. (Pubitemid 351736424)
40. +2 homeostasis and biosynthesis of sterols in Leishmania mexicana . Antimicrob Agents Chemother 53: 1403-1410.
41. Veiga-Santos P, Barrias ES, Santos JF, de Barros Moreira TL, de Carvalho TM. (2012) Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi. Int J Antimicrob Agents 40: 61-71.
42. 24(25)-sterol methyltransferase inhibitors and theirs combinations with ketoconazole. Mol Biochem Parasitol 73: 199-210.
43. Palmié-Peixoto IV, Rocha MR, Urbina JA, de Souza W, Einicker-Lamas M, et al. (2006) Effects of sterol biosynthesis inhibitors on endosymbiont-bearing trypanosomatids. FEMS Microbiol Lett 255: 33-42.
44. Rodrigues CO, Catisti R, Uyemura SA, Vercesi AE, Lira R, et al. (2001) The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin- permeabilization. J Eukaryot Microbiol 48: 588-594. (Pubitemid 32931303)
45. Ogbadoyi EO, Robinson DR, Gull K. (2003) A high-order trans-membrane structural linkage is responsible for mitochondrial genome positioning and segregation by flagellar basal bodies in trypanosomes. Mol Biol Cell 14: 1769-1779. (Pubitemid 36583531)
46. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, et al. (2012) Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 8: 445-544.
47. Menna-Barreto RF, Corrêa JR, Cascabulho CM, Fernandes MC, Pinto AV, et al. (2009) Naphthoimidazoles promote different death phenotypes in Trypanosoma cruzi. Parasitology 136: 499-510.
48. Sengupta S, Chowdhury S, Bosedasgupta S, Wright CW, Majumder HK. (2011) Cryptolepine-induced cell death of Leishmania donovani promastigotes is augmented by inhibition of autophagy. Mol Biol Int 2011: 187850.